HOT

Cagrilintide + Semaglutide

Name: Cagrilintide + Semaglutide Research Peptide
Brand: Purity Peptides
Price: 409 USD
Availability: InStock

CagriSema · Amylin + GLP-1 Dual Combination

Pre-mixed research blend of cagrilintide (amylin analog) and semaglutide (GLP-1 agonist). Studied in dual-mechanism metabolic pathway models.

✓ HPLC Verified ✓ 99%+ Purity ✓ COA Available ✓ Manufacturer Direct ✓ Direct Support

📋 Certificate of Analysis Request COA via Telegram ↗

Research Data

What Is Cagrilintide + Semaglutide?

CagriSema is a fixed-ratio combination of cagrilintide (long-acting amylin receptor agonist) and semaglutide (GLP-1 receptor agonist). Research interest centers on complementary satiety and glycemic mechanisms. Phase 3 REDEFINE trials have shown ~22% body weight reduction data in clinical research.

Research Context

Complementary amylin + GLP-1 receptor co-activation
REDEFINE trial: ~22% weight reduction in clinical research
Satiety pathway convergence at hypothalamic level
Glycemic control modeling beyond GLP-1 monotherapy

Storage & Reconstitution

Store lyophilized at -20°C. Reconstitute with bacteriostatic water. Stable 28 days at 2–8°C post-reconstitution.

Peptide Calculator → Reconstitution Guide →

All products sold for research purposes only. Not for human or animal consumption. Must be 21 or older to purchase. By placing an order you confirm compliance with all applicable local laws and regulations.